Dr. Geoffrey Oxnard on the Most Promising Upcoming New Targeted Agents and Molecular Pathways for Lung Cancer Treatment

Dr. Geoffrey Oxnard on the Most Promising Upcoming New Targeted Agents and Molecular Pathways for Lung Cancer Treatment

Da: GRACEcast
0 0 7 anni fa
00:00
02:18
Medicina, #advanced, #antipd1, #braf, #cancer, #cancergrace, #crizotinib, #dana, #farber, #geoffrey, #grace, #gracecast, #immunotherapy, #institute, #lung, #magea3, #mutation, #oxnard, #ros1, #vemurafenib, #xalkori
Dr. Geoffrey Oxnard, Dana Farber Cancer Institute, provides his view on the targeted therapy approaches most likely to become clinically useful in lung cancer over the next several years.

Autore

cancerGRACE Meetings
cancerGRACE Meetings 2 followers Follow

Seguici su Facebook

Spreaker logo
  • Scegli una lingua

Per podcaster ed editori

Strumenti per i podcaster

Per gli ascoltatori

Copyright 2021 - Spreaker Inc. a Voxnest Company - Crea un podcast - New York, NY